Maze Therapeutics

About:

Maze Therapeutics is an operator of a biotechnology firm used to focus on translating genetic insights into new medicines.

Website: https://www.mazetx.com/

Top Investors: Alexandria Venture Investments, General Catalyst, ARCH Venture Partners, Google Ventures, Foresite Capital

Description:

Maze Therapeutics is a biotechnology firm used to focus on translating genetic insights into new medicines. The company's translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, functional genomics, and an array of drug discovery approaches. and it also reveals modifier genes that confer protection and provide a deeper understanding of the target biology and how these targets can be targeted with drug therapies, enabling patients with protection against diseases.

Total Funding Amount:

$381M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)mazetx.com

Founders:

Charles Homcy

Number of Employees:

101-250

Last Funding Date:

2022-01-10

IPO Status:

Private

© 2025 bioDAO.ai